Metal complexes

Compound for organic electric element, organic electric element using the same, and electronic device comprising same

Compounds for treatment of complement mediated disorders

Ether compounds for treatment of complement mediated disorders

N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases

9H-PYRROLO-DIPYRIDINE DERIVATIVES

Carboxylic acid compound, method for preparation thereof, and use thereof

Compounds for the treatment of hepatitis C

ISOTOPOLOGUES OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE

Aryl substituted indoles and the use thereof

Disconnector device

DEUTERATED TIC10

2-(2,4,5-substituted aniline) pyrimidine derivative, pharmaceutical composition and use thereof

DEUTERIUM-SUBSTITUTED OXADIAZOLES

Deuterated organic compound, mixture and composition containing said compound, and organic electronic device

Organic compounds for organic light-emitting diode and organic light-emitting diode including the same

Radiosynthesiser add-on device

Piercing device

Radioactive iodine labeled pyrido[1,2-a]benzoimidazole derivative compound

18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS

PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES

Double targeted constructs to affect tumor kill

Radioactive halogen-labeled pyrido [1,2-A] benzimidazole derivative compound

COMPOUNDS, COMPOSITIONS, AND METHODS

Sulfur-containing compounds targeting vesicular acetylcholine transporter

Compositions, methods, and systems for the synthesis and use of imaging agents

Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods

Synthesis of meta-substituted [F]-3-fluoro-4-aminopyridines by direct radiofluorination of pyridine N-oxides

Inhibitors of lysine specific demethylase-1

Inhibitors of lysine specific demethylase-1

Creatine prodrugs, compositions and methods of use thereof

Method and catalyst for synthesising aziridine

2',2'-DIHALO NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER

F-18 LABELED TRACER AND METHODS OF MANUFACTURE

DEUTERATED HETEROARYL SULFONAMIDES AND THEIR USE

Fluoride trapping arrangement

Heterocyclic derivatives and their use in the treatment of neurological disorders

DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS

Organic electroluminescence device having at least an a node, a hole injection layer, a first hole transport layer. A second hole transport layer a luminous layer, an electron transport layer, and a cathode

6-aminopyridin-3-yl thiazoles as modulators of RORγT

Compounds and their use as BACE inhibitors

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof

2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's disease

PET tracer purification system

Fuel Markers and Methods of Producing and Using Same

Deuterated quinazolinone compound and pharmaceutical composition comprising same

Substituted bicyclic compounds

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

Amide compounds for treatment of complement mediated disorders

Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams

Deuterated domperidone compositions, methods, and preparation

METHODS OF TREATING NEUROFIBROMATOSIS WITH PERILLYL ALCOHOL

Method for marking oil products and marker composition for oil products

Compositions and methods for imaging

Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases

Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules

METHOD FOR PRODUCING PURE L-HERCYNINE

Anthranilic acid derivatives

Probes for imaging huntingtin protein

RENAL IMAGING AGENT

Method for the production of 18F-labeled active esters and their application exemplified by the preparation of a PSMA-specific PET-tracer

ERK inhibitors

Deuterated triazolopyridazine as a kinase modulator

IRON AND COBALT CATALYZED HYDROGEN ISOTOPE LABELING OF ORGANIC COMPOUNDS

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

Phosphonate compounds for treatment of complement mediated disorders

Biaryl amide compounds as kinase inhibitors

Substituted triazolobenzodiazepines

Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same

Hepatitis B antiviral agents

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

Furopyridine compounds for the treatment of hepatitis C

18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer

Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1)-one derivatives as fungicides

Azetidinyloxyphenylpyrrolidine compounds

Carboxylic acid compound, method for preparation thereof, and use thereof

Inhibitors of ERK and methods of use

CXCR4 receptor antagonists

Metal oxide catalyzed radiofluorination

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

Pyrimidine-2,4-diamine derivatives for treatment of cancer

4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group

DEUTERO-PHENFORMIN DERIVATIVES

IRAK4 inhibiting agents

Deoxycytidine kinase inhibitors

Compositions, methods, and systems for the synthesis and use of imaging agents

Organic compounds

Methods of manufacturing benzoquinoline compounds

1,3,4-thiadiazole compounds and their use in treating cancer

Deuterium substituted 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine compound or derivatives thereof, and pharmaceutical composition and use thereof

Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride

ORGANIC COMPOUNDS

Spirocyclic morphinans and use thereof

IMAGING AGENTS

METHODS OF MANUFACTURING BENZOQUINOLINE COMPOUNDS

Amino compounds for treatment of complement mediated disorders

Deuterated baricitinib

Pyridone derivatives having tetrahydropyranylmethyl groups

METHODS (AMACR)

Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists

6H-furo[2,3-E]indole compounds for the treatment of hepatitis C

Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors

Isotopically modified compounds and their use as food supplements

BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2

COMPOSITIONS AND METHODS FOR SYNTHESIZING (2S,3S)-TRANS-EPOXYSUCCINYL-L-LEUCYL-AMIDO-3-METHYLBUTANE ETHYL ESTER

2-alkoxy-11-hydroxyaporphine derivatives and uses thereof

Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precursors and conjugates thereof

Compositions and methods for inhibition of the JAK pathway

2-(3-pyridinyl)-1H-benzimidazole derivative compound and medicine containing same

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS

Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diols

METHOD AND CATALYST FOR SYNTHESISING AZIRIDINE

Isobaric mass labels

Inhibitors of CXCR2

Deuterated momelotinib

DEUTERATED CFTR POTENTIATORS

Fluorination method

FOLATE-CONJUGATES AND CORRESPONDING METAL-CHELATE COMPLEXES FOR USE IN DIAGNOSTIC IMAGING AND RADIOTHERAPY

Formulation and method of synthesis

Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof

IMMUNO-PET IMAGING OF ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR

Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrillary

Radiolabeled compounds

Deuterated compounds for treating hematologic malignancies, and compositions and methods thereof

Compounds and methods of use to treat schizophrenia

Inhibitors of lysine specific demethylase-1

HETEROCYCLIC COMPOUND

FLUORINATED 2-AMINO-4-(BENZYLAMINO)PHENYLCARBAMATE DERIVATIVES

Multivalent ligands targeting VEGFR

Chelated PSMA inhibitors

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors

LXR agonists and uses thereof

Fluorescent labeled inhibitors

TYK2 inhibitors and uses thereof

Radioactive fluorine labeling precursor compound and method for manufacturing radioactive fluorine labeled compound using the same

Analogs of fexaramine and methods of making and using

Probes for imaging Huntingtin protein

Inhibitors of creatine transport and uses thereof

Deuterated pentylenetetrazoles for improving cognitive function

2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors

Methods for preparing triazole agonists of the APJ receptor

Oxaspiro[2.5]Octane Derivatives and Analogs

RADIOCONJUGATION METHOD

Substituted bicyclic compounds

Intermediates for preparing triazole agonists of the APJ receptor

Triazole agonists of the APJ receptor

Triazole agonists of the APJ receptor

Lipophenol compounds and uses thereof

Organic compounds

10-substituted morphinan hydantoins

Triazole agonists of the APJ receptor

Opsin-Binding Ligands, Compositions and Methods of Use

Copper catalyzed [18F]fluorination of iodonium salts

Small molecule drug conjugates

Intermediates for preparing triazole agonists of the APJ receptor

Methods and reagents for radiolabeling

Allenamide as an orthogonal handle for selective modification of cysteine in peptides and proteins

Methods of protecting an organ using tetrahydrocurcumin and phosphatidylcholine

Condensed 5-oxazolidinone derivative

Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Method for producing 4-borono-L-phenylalanine having 18F atom introduced thereinto, and precursor of 4-borono-L-phenylalanine having 18F atom introduced thereinto

Deuterated ibrutinib

COT MODULATORS AND METHODS OF USE THEREOF

Pyridines and pyrimidines and use thereof

Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases

Heatseal

CYCLOPROPYL MODULATORS OF P2Y12 RECEPTOR

Indazoles and use thereof

Bicyclic or tricyclic heterocyclic compound

FXR agonists and methods for making and using

QUINOLONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2

SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS

Therapeutic compounds

Compositions and methods for biological production of lactate from Ccompounds using lactate dehydrogenase transformants

Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

HALOGENATED COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE

Cyclic peroxides as prodrugs for selective delivery of agents

Bridged bicyclic kallikrein inhibitors

Amide compounds for treatment of complement mediated disorders

Iodine(II)-mediated radiofluorination

Compositions, methods, and systems for the synthesis and use of imaging agents

COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

PROCESS FOR PRODUCING GALLIUM-68 THROUGH THE IRRADIATION OF A SOLUTION TARGET

Preparation of hydroxy-benzylbenzene derivatives

Preparation of 18F-fluciclovine

Cage amine ligands for metallo-radiopharmaceuticals

Deuterium-enriched pioglitazone

Fused heterocyclic compounds as ion channel modulators

COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN

A KIT FOR PREPARING A RADIOPHARMACEUTICAL

Substituted triazolobenzodiazepines

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors

Piperidine inhibitors of Janus kinase 3

Cognition enhancing compounds and compositions, methods of making, and methods of treating

Triazole agonists of the APJ receptor

Co-crystals and pharmaceutical compositions comprising the same

Proteasome activity enhancing compounds

Modulators of ATP-binding cassette transporters

Pyrimidines and use thereof

Processes for the synthesis of chiral 1-alkanols

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereof

Ionic liquid supported organotin reagents for the manufacturing of radiopharmaceuticals compounds

Organic compounds

ARYL SUBSTITUTED INDOLES AND THE USE THEREOF

4-hydroxybutyric acid analogs

Pyridone-sulfone morphinan analogs as opioid receptor ligands

SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY

HETEROARYL COMPOUNDS AND USES THEREOF

Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy

Mass spectrometric identification and/or quantitation of catecholamines using aminopyrazoles

PURIFICATION METHOD AND COMPOSITIONS

Probes and methods of imaging a bacterial infection

METHODS OF TREATING ABNORMAL MUSCULAR ACTIVITY

N-substituted benzamides and methods of use thereof

HYPERPOLARIZED 1-13C-1,1-BIS(ACETOXY(METHYL))-2,2'-CYCLOPROPANE AS METABOLIC MARKER FOR MR

Creatine phosphate analog prodrugs, compositions and methods of use thereof

Picolinate cross-bridged cyclams, chelates with metallic cations and use thereof

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor

Fuel markers and methods of producing and using same

Fuel markers and methods of producing and using same

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors

Fluorination of organic compounds

Tau imaging probe

Imaging histone deacetylases with a radiotracer using positron emission tomography

Bifunctional cytotoxic agents containing the CTI pharmacophore

VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA

GDF-8 inhibitors

SUBSTITUTED ISOINDOLINE-1,3-DIONE DERIVATIVES

C-HALOGEN BOND FORMATION

Radiotracer introduced [18F]fluoromethyl group targeting neuroinflammation for PET imaging and Synthesis of Radiotracer and its biological evaluation Method for Radiotracer

Process for the preparation of hyperpolarized carboxylate compounds

CLOSED EVAPORATION SYSTEM

Phenyl glyoxal probes

Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors

OXINDOLE INHIBITORS OF TYROSINE KINASE

Radioligands for imaging the LPA-1 receptor

Deuterated compounds and uses thereof

TAU IMAGING PROBE

Labeled pkg-1-alpha-binding compounds and their use in imaging and quantifying pain

Triazolopyridine ether derivatives and their use in neurological and pyschiatric disorders

Deoxycytidine kinase inhibitors

KDM1A inhibitors for the treatment of disease

Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

3-(1-pyrazol-4-yl)-1-pyrrolo[2,3-]pyridine derivatives as NIK inhibitors

Glucosylceramide synthase inhibitors for the treatment of diseases

Compounds and Their Use for Preparation of Tau Imaging Agents and Tau Imaging Formulations

Aza-pyridone compounds and uses thereof

DEUTERATED COMPOUNDS

Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

Cognition enhancing compounds and compositions, methods of making, and methods of treating

Method for detecting and determining levels of monolignol ester conjugates incorporated into lignin and compounds relating thereto

Method for production of F-18 labeled amyloid beta ligands

Synthesis of [F]-fluoroalkyl tosylate

F-labelled folates

Deuterated rigosertib

Inhibitors of lysine specific demethylase-1

3-aryl propiolonitrile compounds for thiol labeling

Synthesis of fluorinated radiopharmaceuticals via electrochemical fluorination

Modular radiochemistry synthesis system

Inhibitors of lysine specific demethylase-1

Method for preparing deuterated aromatic compounds

Bicyclic aza compounds as muscarinic M1 receptor agonists

4,6-DIAMINOPYRIMIDINE STIMULATORS OF SOLUBLE GUANYLATE CYCLASE

Inhibitors of cholesterol ester transfer protein

Device and method for the production of radiochemical compounds

PSMA-binding agents and uses thereof

Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate

Digital microfluidic platform for radiochemistry

Fused heterocyclic compounds as ion channel modulators

Pyrimidinones as factor XIa inhibitors

Precursor compound of radioactive halogen-labeled organic compound

Stabilization of radiosynthetic intermediates

Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase

Substituted bicyclic compounds

Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

Radiolabelling process

IMIDAZOLIDINONES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES

Pharmaceutical Compositions Comprising Deuterium-Enriched Perillyl Alcohol, Iso-Perillyl Alcohol and Derivatives Thereof

Aromatic amino acid derivative and positron emission topography (PET) probe using the same

RADIOLABELED COMPOUNDS

Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine

Lysine isotopologues, compositions comprising the same and methods of synthesis

Vinylsulfone-based 18F-labeling compositions and methods and uses thereof

2',6'-DIOXO-3'-DEUTERO-PIPERDIN-3-YL-ISOINDOLINE COMPOUNDS

Precursor compound of radioactive halogen-labeled organic compound

Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds

Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging

RADIOLABELED QUINAZOLINE DERIVATIVES

METHOD OF SYNTHESIZING FLUORINE-18 LABELED RADIOPHARMACEUTICALS IN ETHANOL AND WATER

Amine-based compound and organic light-emitting device including the same

Super lewis acidic borate esters as 18F-labeled PET probes

Deuterated momelotinib

Amine-based compound and organic light-emitting device including the same

COMPOUNDS AND THERAPEUTIC USES THEREOF